A Randomized Study of Trastuzumab and Pertuzumab (TP) Compared to Cetuximab and Irinotecan (CETIRI) in Advanced/Metastatic Colorectal Cancer with HER2 Amplification (S1613)
A Randomized Study of Trastuzumab and Pertuzumab (TP) Compared to Cetuximab and Irinotecan (CETIRI) in Advanced/Metastatic Colorectal Cancer with HER2 Amplification (S1613)
Trial Category:
Gastrointestinal
Phase
II
Contact(s)
Location(s)
Methodist Estabrook Cancer Center, Omaha, NE
